Alyeska Investment Group L.P. lowered its holdings in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 82.6% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 975,864 shares of the real estate investment trust's stock after selling 4,640,803 shares during the quarter. Alyeska Investment Group L.P. owned 0.14% of Healthpeak Properties worth $20,883,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Advocate Investing Services LLC acquired a new position in shares of Healthpeak Properties during the fourth quarter worth approximately $26,000. Clearstead Trust LLC grew its stake in shares of Healthpeak Properties by 66.7% in the second quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust's stock worth $29,000 after acquiring an additional 543 shares during the last quarter. Elyxium Wealth LLC acquired a new stake in shares of Healthpeak Properties in the fourth quarter worth $31,000. Clearstead Advisors LLC increased its position in Healthpeak Properties by 166.3% during the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust's stock worth $31,000 after acquiring an additional 1,216 shares during the period. Finally, CYBER HORNET ETFs LLC bought a new position in Healthpeak Properties during the second quarter worth $33,000. Institutional investors and hedge funds own 93.57% of the company's stock.
Healthpeak Properties Trading Down 0.8%
Shares of Healthpeak Properties stock opened at $20.80 on Tuesday. The stock has a market capitalization of $14.34 billion, a P/E ratio of 59.43, a price-to-earnings-growth ratio of 2.29 and a beta of 1.01. The company has a quick ratio of 3.02, a current ratio of 3.02 and a debt-to-equity ratio of 1.06. The company has a 50-day simple moving average of $21.56 and a 200 day simple moving average of $19.23. Healthpeak Properties, Inc. has a 12-month low of $15.70 and a 12-month high of $22.95.
Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.05. The firm had revenue of $771.58 million during the quarter, compared to the consensus estimate of $725.64 million. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The firm's quarterly revenue was up 11.1% on a year-over-year basis. During the same period last year, the firm posted $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Research analysts expect that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current fiscal year.
Healthpeak Properties Announces Dividend
The firm also recently declared a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be given a dividend of $0.1017 per share. The ex-dividend date is Monday, September 14th. This represents a c) dividend on an annualized basis and a yield of 5.9%. Healthpeak Properties's dividend payout ratio is 348.57%.
Analyst Upgrades and Downgrades
DOC has been the subject of several research reports. Royal Bank Of Canada increased their target price on shares of Healthpeak Properties from $21.00 to $24.00 and gave the company an "outperform" rating in a research note on Monday, August 10th. Wells Fargo & Company boosted their price target on Healthpeak Properties from $20.00 to $22.00 and gave the company an "equal weight" rating in a research note on Wednesday, July 15th. Citigroup upped their price target on Healthpeak Properties from $20.00 to $22.00 and gave the company a "neutral" rating in a report on Tuesday, August 11th. Morgan Stanley reissued an "equal weight" rating and set a $22.00 price objective (up from $20.00) on shares of Healthpeak Properties in a report on Thursday, June 11th. Finally, Barclays lifted their price objective on Healthpeak Properties from $23.00 to $24.00 and gave the stock an "equal weight" rating in a report on Monday. Four investment analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $21.72.
View Our Latest Stock Analysis on DOC
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
See Also
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.